The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
2022 · Leukemia · 3,654 citations
https://doi.org/10.1038/s41375-022-01613-1
C
Claire Harrison
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
846
Papers
34.7K
Citations
80
h-index
317
i10-index
Claire Harrison is an academic researcher from National Health Service. The author has contributed to research in topics: Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments & Acute Myeloid Leukemia Research. The author has an h-index of 80, co-authored 720 publications.
ORCID: 0000-0002-3212-920XPapers by this author
worksClassification and Personalized Prognosis in Myeloproliferative Neoplasms
2018 · New England Journal of Medicine · 586 citations
https://doi.org/10.1056/nejmoa1716614
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
2018 · Leukemia · 538 citations
https://doi.org/10.1038/s41375-018-0077-1
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis
2015 · JAMA Oncology · 453 citations
https://doi.org/10.1001/jamaoncol.2015.1590
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
2012 · Journal of Clinical Oncology · 444 citations
https://doi.org/10.1200/jco.2012.42.3863
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study
2017 · The Lancet Haematology · 318 citations
https://doi.org/10.1016/s2352-3026(17)30088-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat